10X Genomics Inc

詳細情報 10X Genomics Inc 企業名

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.

企業情報

企業コードTXG

会社名10X Genomics Inc

上場日Sep 12, 2019

設立日2012

最高経営責任者「CEO」Mr. Serge Wilson Saxonov, Ph.D.

従業員数1306

証券種類Ordinary Share

決算期末Sep 12

本社所在地6230 Stoneridge Mall Road

都市PLEASANTON

証券取引所NASDAQ Global Select Consolidated

国United States of America

郵便番号94588

電話番号19254017300

ウェブサイトhttps://www.10xgenomics.com/

企業コードTXG

上場日Sep 12, 2019

設立日2012

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Serge Wilson Saxonov, Ph.D.

Chief Executive Officer, Co-Founder, Director

1.07M

-0.09%

Dr. John R. Stuelpnagel

Independent Chairman of the Board

369.61K

+4.34%

Whitaker (Eric S)

Chief Legal Officer

202.20K

+29.09%

Mr. Sridhar (Sri) Kosaraju

Independent Director

59.45K

+34.83%

Dr. Benjamin J. Hindson, Ph.D.

President, Co-Founder, Chief Scientific Officer, Director

52.17K

-12.55%

Ms. Kimberly J. (Kim) Popovits

Independent Director

28.62K

+115.82%

Dr. Shehnaaz Suliman, M.D.

Independent Director

28.62K

+115.82%

Mr. Adam S. Taich

Chief Financial Officer

--

Mr. Alan V. Mateo

Independent Director

--

Dr. Sarah A. Teichmann

Independent Director

--

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Serge Wilson Saxonov, Ph.D.

Chief Executive Officer, Co-Founder, Director

1.07M

-0.09%

Dr. John R. Stuelpnagel

Independent Chairman of the Board

369.61K

+4.34%

Whitaker (Eric S)

Chief Legal Officer

202.20K

+29.09%

Mr. Sridhar (Sri) Kosaraju

Independent Director

59.45K

+34.83%

Dr. Benjamin J. Hindson, Ph.D.

President, Co-Founder, Chief Scientific Officer, Director

52.17K

-12.55%

Ms. Kimberly J. (Kim) Popovits

Independent Director

28.62K

+115.82%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Consumables

115.36M

74.48%

Products and services revenue

17.06M

11.01%

Instruments

14.81M

9.57%

Services

7.65M

4.94%

地域別USD

会社名

収益

比率

United States

86.82M

56.05%

Europe, the Middle East and Africa

31.89M

20.59%

China

16.88M

10.90%

Asia Pacific

15.54M

10.03%

Americas

3.75M

2.42%

事業別

地域別

事業別USD

会社名

収益

比率

Consumables

115.36M

74.48%

Products and services revenue

17.06M

11.01%

Instruments

14.81M

9.57%

Services

7.65M

4.94%

株主

更新時刻: Fri, May 23

株主統計

種類

株主統計

比率

ARK Investment Management LLC

11.56%

The Vanguard Group, Inc.

9.99%

Fidelity Management & Research Company LLC

7.72%

Millennium Management LLC

4.98%

BlackRock Institutional Trust Company, N.A.

4.87%

Other

60.88%

株主統計

比率

ARK Investment Management LLC

11.56%

The Vanguard Group, Inc.

9.99%

Fidelity Management & Research Company LLC

7.72%

Millennium Management LLC

4.98%

BlackRock Institutional Trust Company, N.A.

4.87%

Other

60.88%

種類

株主統計

比率

Investment Advisor

45.04%

Investment Advisor/Hedge Fund

22.18%

Hedge Fund

19.03%

Bank and Trust

5.32%

Research Firm

5.16%

Venture Capital

3.69%

Individual Investor

1.92%

Pension Fund

0.68%

Family Office

0.30%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

656

115.46M

103.93%

-12.51M

2025Q1

687

115.67M

104.27%

-8.84M

2024Q4

689

107.08M

98.92%

-12.41M

2024Q3

682

106.90M

100.39%

-9.08M

2024Q2

691

105.36M

99.70%

-5.09M

2024Q1

762

106.36M

101.17%

-3.12M

2023Q4

817

100.80M

96.01%

-9.73M

2023Q3

835

96.86M

93.80%

-12.55M

2023Q2

857

94.98M

96.77%

-15.37M

2023Q1

864

95.62M

97.55%

-9.91M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

ARK Investment Management LLC

12.85M

11.56%

+901.66K

+7.55%

Mar 31, 2025

The Vanguard Group, Inc.

11.09M

9.99%

+184.54K

+1.69%

Mar 31, 2025

Fidelity Management & Research Company LLC

8.58M

7.72%

-2.75M

-24.30%

Mar 31, 2025

Millennium Management LLC

5.53M

4.98%

+156.13K

+2.90%

Apr 01, 2025

BlackRock Institutional Trust Company, N.A.

5.41M

4.87%

-108.37K

-1.96%

Mar 31, 2025

Sumitomo Mitsui Trust Bank, Limited

5.36M

4.83%

+5.36M

--

Mar 31, 2025

UBS Asset Management (Switzerland)

4.10M

3.69%

+2.13M

+108.14%

Mar 31, 2025

Two Sigma Investments, LP

3.17M

2.85%

+614.32K

+24.04%

Mar 31, 2025

UBS Asset Management (Americas) LLC

2.90M

2.61%

+2.85M

+4.95K%

Mar 31, 2025

BofA Global Research (US)

2.56M

2.3%

+2.03M

+386.97%

Mar 31, 2025

詳細を見る

11.940USD

10X Genomics Inc

11.940

概要

企業名